标题
Effects of DPP-4 Inhibitors on the Heart in a Rat Model of Uremic Cardiomyopathy
作者
关键词
-
出版物
PLoS One
Volume 6, Issue 11, Pages e27861
出版商
Public Library of Science (PLoS)
发表日期
2011-11-19
DOI
10.1371/journal.pone.0027861
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Endothelin-1 overexpression restores diastolic function in eNOS knockout mice
- (2011) Nicolas Vignon-Zellweger et al. JOURNAL OF HYPERTENSION
- Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus
- (2010) Xiaoxiang Yan et al. Cardiovascular Diabetology
- Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering Therapies: A retrospective analysis of the LifeLink database
- (2010) J. H. Best et al. DIABETES CARE
- Pharmacokinetics of dipeptidylpeptidase-4 inhibitors
- (2010) A. J. Scheen DIABETES OBESITY & METABOLISM
- The Metabolism and Disposition of the Oral Dipeptidyl Peptidase-4 Inhibitor, Linagliptin, in Humans
- (2010) S. Blech et al. DRUG METABOLISM AND DISPOSITION
- GLP-1 signaling preserves cardiac function in endotoxemic Fischer 344 and DPP4-deficient rats
- (2010) Hui-Chun Ku et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control?
- (2009) David J Grieve et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patients
- (2009) T. Heise et al. DIABETES OBESITY & METABOLISM
- Spironolactone Attenuates Experimental Uremic Cardiomyopathy by Antagonizing Marinobufagenin
- (2009) Jiang Tian et al. HYPERTENSION
- BNP-Guided vs Symptom-Guided Heart Failure Therapy
- (2009) Matthias Pfisterer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Vascular Calcification: The Killer of Patients with Chronic Kidney Disease
- (2009) M. Mizobuchi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The cardioprotective and inotropic components of the postconditioning effects of GLP-1 and GLP-1(9–36)a in an isolated rat heart
- (2009) Alvilde Ossum et al. PHARMACOLOGICAL RESEARCH
- Cystatin C for early detection of renal impairment in diabetes
- (2008) D. Willems et al. CLINICAL BIOCHEMISTRY
- Cystatin C improves the diagnosis and stratification of chronic kidney disease, and the estimation of glomerular filtration rate in diabetes
- (2008) V. Rigalleau et al. DIABETES & METABOLISM
- Interrelationship of dipeptidyl peptidase IV (DPP4) with the development of diabetes, dyslipidaemia and nephropathy: a streptozotocin-induced model using wild-type and DPP4-deficient rats
- (2008) Yasushi Kirino et al. JOURNAL OF ENDOCRINOLOGY
- Low-Dose Growth Hormone is Cardioprotective in Uremia
- (2008) R. Rabkin et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The adenosine A1 receptor antagonist SLV320 reduces myocardial fibrosis in rats with 5/6 nephrectomy without affecting blood pressure
- (2007) P Kalk et al. BRITISH JOURNAL OF PHARMACOLOGY
- NO-independent activation of soluble guanylate cyclase prevents disease progression in rats with 5/6 nephrectomy
- (2006) Philipp Kalk et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now